BLMH Quote, Financials, Valuation and Earnings

Ladybug Resource Group has a net margin of -76.63% compared to Blum Holdings's net margin of --. Blum Holdings's return on equity of -- beat Ladybug Resource Group's return on equity of --.

Blum Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Ladybug Resource Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Blum Holdings has higher upside potential than Ladybug Resource Group, analysts believe Blum Holdings is more attractive than Ladybug Resource Group.

Blum Holdings has a beta of 2.463, which suggesting that the stock is 146.254% more volatile than S&P 500. In comparison Ladybug Resource Group has a beta of -9.113, suggesting its less volatile than the S&P 500 by 1011.333%.

Blum Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ladybug Resource Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Blum Holdings pays -- of its earnings as a dividend. Ladybug Resource Group pays out -- of its earnings as a dividend.

Blum Holdings quarterly revenues are $4.4M, which are larger than Ladybug Resource Group quarterly revenues of --. Blum Holdings's net income of -$3.3M is higher than Ladybug Resource Group's net income of --. Notably, Blum Holdings's price-to-earnings ratio is -- while Ladybug Resource Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blum Holdings is 0.43x versus -- for Ladybug Resource Group. Usually stocks with elevated PS ratios are considered overvalued.

Medicine Man Technologies has a net margin of -76.63% compared to Blum Holdings's net margin of -32.23%. Blum Holdings's return on equity of -- beat Medicine Man Technologies's return on equity of -39.36%.

Blum Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Medicine Man Technologies has an analysts' consensus of $2.64 which suggests that it could grow by 13101.65%. Given that Medicine Man Technologies has higher upside potential than Blum Holdings, analysts believe Medicine Man Technologies is more attractive than Blum Holdings.

Blum Holdings has a beta of 2.463, which suggesting that the stock is 146.254% more volatile than S&P 500. In comparison Medicine Man Technologies has a beta of 2.010, suggesting its more volatile than the S&P 500 by 101.023%.

Blum Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medicine Man Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Blum Holdings pays -- of its earnings as a dividend. Medicine Man Technologies pays out -- of its earnings as a dividend.

Blum Holdings quarterly revenues are $4.4M, which are smaller than Medicine Man Technologies quarterly revenues of $43.2M. Blum Holdings's net income of -$3.3M is higher than Medicine Man Technologies's net income of -$13.9M. Notably, Blum Holdings's price-to-earnings ratio is -- while Medicine Man Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blum Holdings is 0.43x versus 0.01x for Medicine Man Technologies. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -76.63% compared to Blum Holdings's net margin of -6.93%. Blum Holdings's return on equity of -- beat SunLink Health Systems's return on equity of -5.08%.

Blum Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Blum Holdings has higher upside potential than SunLink Health Systems, analysts believe Blum Holdings is more attractive than SunLink Health Systems.

Blum Holdings has a beta of 2.463, which suggesting that the stock is 146.254% more volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.398, suggesting its more volatile than the S&P 500 by 39.847%.

Blum Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Blum Holdings pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Blum Holdings quarterly revenues are $4.4M, which are smaller than SunLink Health Systems quarterly revenues of $7.9M. Blum Holdings's net income of -$3.3M is lower than SunLink Health Systems's net income of -$549K. Notably, Blum Holdings's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blum Holdings is 0.43x versus 0.24x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of -76.63% compared to Blum Holdings's net margin of -8%. Blum Holdings's return on equity of -- beat Walgreens Boots Alliance's return on equity of -43.52%.

Blum Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of $10.36 which suggests that it could grow by 9.37%. Given that Walgreens Boots Alliance has higher upside potential than Blum Holdings, analysts believe Walgreens Boots Alliance is more attractive than Blum Holdings.

Blum Holdings has a beta of 2.463, which suggesting that the stock is 146.254% more volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.646, suggesting its less volatile than the S&P 500 by 35.445%.

Blum Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 10.56% to investors and pays a quarterly dividend of $0.25 per share. Blum Holdings pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

Blum Holdings quarterly revenues are $4.4M, which are smaller than Walgreens Boots Alliance quarterly revenues of $37.5B. Blum Holdings's net income of -$3.3M is higher than Walgreens Boots Alliance's net income of -$3B. Notably, Blum Holdings's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blum Holdings is 0.43x versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.